Organisation paid for research Program year 2025 Source: CMS Open Payments

Advanced Cardiology Associates

Neither a doctor nor a teaching hospital

Research payments

$124,790

7 payments

Through program year 2025, Advanced Cardiology Associates is reported as receiving $124,790 in research payments, across 7 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$18,536	3
2024	Research	$76,108	2
2023	Research	$23,621	1
2019	Research	$6,525	1

Breakdown

Who paid Research payments · program years 2019–2025

Amgen Inc. $118,265 6 payments
Novartis Pharmaceuticals Corporation $6,525 1 payment

Studies the money was for Research payments · program years 2019–2025

OCEANa-Outcomes P3 CV $76,108 2 payments
Phase 3 - Cardiovascular Outcomes Trial $23,621 1 payment
A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Olpasiran on Major Cardiovascular Events in Participants With Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein(a) $16,004 1 payment
Observational Registry of Treatment Patterns in US Heart Failure Patients With Reduced Ejection Fraction $6,525 1 payment
A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing Olpasiran Use to Prevent First Major Cardiovascular Events in Participants With Elevated Lipoprotein(a) $1,613 1 payment
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Maridebart Cafraglutide on Mortality and Morbidity in Participants Living With Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF) $919 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.